TYP fundamentals
An in-depth look to TRYPTAMINE THERAPEUTICS LIMITED operating, investing, and financing activities
TYP free cash flow for H1 25 is -5.15 M AUD. For 2024, TYP free cash flow was -6 M AUD and operating cash flow was -6 M AUD.
H1 '19
H2 '19
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−12.00 M
−6.00 M
0.00
6.00 M
12.00 M
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
H1 '19
Dec 2018
H2 '19
Jun 2019
H1 '20
Dec 2019
H2 '20
Jun 2020
H1 '21
Dec 2020
H2 '21
Jun 2021
H1 '22
Dec 2021
H2 '22
Jun 2022
H1 '23
Dec 2022
H2 '23
Jun 2023
H1 '24
Dec 2023
H2 '24
Jun 2024
H1 '25
Dec 2024
TTM
Cash from operating activitiesYoY growth
−3.11 M
+50.45%
1.66 M
—
−7.54 M
−142.28%
−5.03 M
−402.90%
−12.57 M
Cash from investing activitiesYoY growth
−123.44 K
+75.20%
695.90 K
—
988.60 K
—
−120.72 K
−117.35%
867.88 K
Cash from financing activitiesYoY growth
3.20 M
+41.33%
−1.39 M
+33.28%
10.54 M
+229.88%
2.55 M
—
13.10 M